Impact on physical function of the +AGIL Barcelona program in community-dwelling older adults with cognitive impairment: an interventional cohort study.


Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
13 Nov 2023
Historique:
received: 11 01 2023
accepted: 08 09 2023
medline: 15 11 2023
pubmed: 14 11 2023
entrez: 14 11 2023
Statut: epublish

Résumé

Older adults with cognitive impairment (CI) have higher multimorbidity and frailty prevalence, lower functional status and an increased likelihood to develop dementia, non-cognitive deficits, and adverse health-related events. +AGIL, a real-world program for frail older adults in a primary care area of Barcelona, is a pragmatic, multi-component and integrated intervention implemented since 2016. It includes physical activity, nutrition, sleep hygiene, revision and adequacy of pharmacological treatment, detection of undesired loneliness and screening for CI; to improve physical function in community-dwelling older adults. We aimed to assess the + AGIL longitudinal impact on physical function among community-dwelling frail older persons with CI. An interventional cohort study included data from all the + AGIL consecutive participants from July 2016 until March 2020. Based on the comprehensive geriatric assessment, participants were offered a tailored multi-component community intervention, including a 10-week physical activity program led by an expert physical therapist. Physical performance was measured at baseline, three and six months follow-up. The pre-post impact on physical function was assessed by paired sample t-test for repeated samples. Linear mixed models were applied to analyze the + AGIL longitudinal impact. P-values < 0.05 were considered statistically significant. 194 participants were included (82 with CI, based on previous diagnosis or the Mini-COG screening tool), 68% women, mean age 81.6 (SD = 5.8) yo. Participants were mostly independent in Activities of Daily Living (mean Barthel = 92.4, SD = 11.1). The physical activity program showed high adherence (87.6% attended ≥ 75% sessions). At three months, there was a clinically and statistically significant improvement in the Short Physical Performance Battery (SPPB) and its subcomponents in the whole sample and after stratification for CI [CI group improvements: SPPB = 1.1 (SD = 1.8) points, gait speed (GS) = 0.05 (SD = 0.13) m/s, Chair stand test (CST)=-2.6 (SD = 11.4) s. Non-CI group improvements: SPPB = 1.6 (SD = 1.8) points, GS = 0.08 (SD = 0.13) m/s, CST=-6.4 (SD = 12.1) seg]. SPPB and gait speed remained stable at six months in the study sample and subgroups. CI had no significant impact on SPPB or GS improvements. Our results suggest that older adults with CI can benefit from a multidisciplinary integrated and comprehensive geriatric intervention to improve physical function, a component of frailty.

Sections du résumé

BACKGROUND BACKGROUND
Older adults with cognitive impairment (CI) have higher multimorbidity and frailty prevalence, lower functional status and an increased likelihood to develop dementia, non-cognitive deficits, and adverse health-related events. +AGIL, a real-world program for frail older adults in a primary care area of Barcelona, is a pragmatic, multi-component and integrated intervention implemented since 2016. It includes physical activity, nutrition, sleep hygiene, revision and adequacy of pharmacological treatment, detection of undesired loneliness and screening for CI; to improve physical function in community-dwelling older adults. We aimed to assess the + AGIL longitudinal impact on physical function among community-dwelling frail older persons with CI.
METHODS METHODS
An interventional cohort study included data from all the + AGIL consecutive participants from July 2016 until March 2020. Based on the comprehensive geriatric assessment, participants were offered a tailored multi-component community intervention, including a 10-week physical activity program led by an expert physical therapist. Physical performance was measured at baseline, three and six months follow-up. The pre-post impact on physical function was assessed by paired sample t-test for repeated samples. Linear mixed models were applied to analyze the + AGIL longitudinal impact. P-values < 0.05 were considered statistically significant.
RESULTS RESULTS
194 participants were included (82 with CI, based on previous diagnosis or the Mini-COG screening tool), 68% women, mean age 81.6 (SD = 5.8) yo. Participants were mostly independent in Activities of Daily Living (mean Barthel = 92.4, SD = 11.1). The physical activity program showed high adherence (87.6% attended ≥ 75% sessions). At three months, there was a clinically and statistically significant improvement in the Short Physical Performance Battery (SPPB) and its subcomponents in the whole sample and after stratification for CI [CI group improvements: SPPB = 1.1 (SD = 1.8) points, gait speed (GS) = 0.05 (SD = 0.13) m/s, Chair stand test (CST)=-2.6 (SD = 11.4) s. Non-CI group improvements: SPPB = 1.6 (SD = 1.8) points, GS = 0.08 (SD = 0.13) m/s, CST=-6.4 (SD = 12.1) seg]. SPPB and gait speed remained stable at six months in the study sample and subgroups. CI had no significant impact on SPPB or GS improvements.
CONCLUSION CONCLUSIONS
Our results suggest that older adults with CI can benefit from a multidisciplinary integrated and comprehensive geriatric intervention to improve physical function, a component of frailty.

Identifiants

pubmed: 37957601
doi: 10.1186/s12877-023-04292-4
pii: 10.1186/s12877-023-04292-4
pmc: PMC10644445
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

736

Informations de copyright

© 2023. The Author(s).

Références

Exp Gerontol. 2016 Mar;75:42-7
pubmed: 26707711
Clin Geriatr Med. 2017 Aug;33(3):293-303
pubmed: 28689563
Int J Environ Res Public Health. 2021 Jun 09;18(12):
pubmed: 34207701
Aviat Space Environ Med. 2005 Jun;76(6 Suppl):B192-7
pubmed: 15943212
Age (Dordr). 2014 Apr;36(2):801-11
pubmed: 24243397
J Nutr Health Aging. 2009 Jun;13(6):538-44
pubmed: 19536422
Psychol Med. 2009 Jan;39(1):3-11
pubmed: 18570697
Am J Geriatr Psychiatry. 2012 Oct;20(10):845-53
pubmed: 23011051
J Gerontol A Biol Sci Med Sci. 2019 May 16;74(6):943-948
pubmed: 29917045
Gait Posture. 2010 May;32(1):87-91
pubmed: 20434917
J Gerontol A Biol Sci Med Sci. 2000 Apr;55(4):M221-31
pubmed: 10811152
Eur J Epidemiol. 2013 Mar;28(3):277-83
pubmed: 23385659
Clin Interv Aging. 2017 May 17;12:835-845
pubmed: 28553092
JAMA Intern Med. 2015 Jul;175(7):1094-1103
pubmed: 25961184
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD002759
pubmed: 19588334
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
Lancet Neurol. 2018 Nov;17(11):1006-1015
pubmed: 30244829
J Am Geriatr Soc. 2009 Mar;57(3):453-61
pubmed: 19245415
J Frailty Aging. 2015;4(1):13-25
pubmed: 27031911
Rev Neurol (Paris). 2019 Dec;175(10):724-741
pubmed: 31521398
J Am Med Dir Assoc. 2020 Oct;21(10):1415-1422.e6
pubmed: 32981668
J Nutr Health Aging. 2018;22(7):790-795
pubmed: 30080221
J Physiother. 2018 Jan;64(1):4-15
pubmed: 29289581
J Nutr Health Aging. 2011 Apr;15(4):271-6
pubmed: 21437558
Cochrane Database Syst Rev. 2019 Sep 14;9:CD011414
pubmed: 31521064
Neurology. 2008 Aug 12;71(7):499-504
pubmed: 18695161
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Age Ageing. 2015 Mar;44(2):213-8
pubmed: 25324330
Arch Neurol. 2001 Mar;58(3):498-504
pubmed: 11255456
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Neurology. 2012 Apr 24;78(17):1323-9
pubmed: 22517108
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
J Am Geriatr Soc. 2019 Apr;67(4):674-694
pubmed: 30693946
Ageing Res Rev. 2017 Aug;37:117-134
pubmed: 28587957
JAMA Intern Med. 2019 Jan 1;179(1):28-36
pubmed: 30419096
Exp Gerontol. 2019 Jul 15;122:10-14
pubmed: 30995516
Eur J Intern Med. 2018 Oct;56:57-63
pubmed: 30145055
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
BMC Geriatr. 2022 May 12;22(1):417
pubmed: 35549672
Ann Geriatr Med Res. 2020 Mar;24(1):3-14
pubmed: 32743316
J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):884-893
pubmed: 35150086
Phys Ther. 2008 Dec;88(12):1482-91
pubmed: 18820094
J Am Geriatr Soc. 2017 Jul;65(7):1566-1568
pubmed: 28263366
Arch Intern Med. 2010 Jan 25;170(2):186-93
pubmed: 20101014
J Am Geriatr Soc. 2015 Sep;63(9):1783-90
pubmed: 26311270
J Am Diet Assoc. 2008 Jul;108(7):1134-44; discussion 1145
pubmed: 18589019
Nat Rev Neurol. 2018 Nov;14(11):653-666
pubmed: 30291317
Acta Biomed. 2018 Jun 07;89(2):276-290
pubmed: 29957766
J Nutr Health Aging. 2019;23(8):710-716
pubmed: 31560028
Neurotoxicology. 2017 Jul;61:143-187
pubmed: 28363508
Innov Aging. 2020 Oct 12;4(6):igaa050
pubmed: 33241126
J Am Geriatr Soc. 2012 Mar;60(3):413-9
pubmed: 22288835
PLoS One. 2015 Apr 13;10(4):e0122878
pubmed: 25875165
Sleep Med Rev. 2018 Aug;40:4-16
pubmed: 28890168

Auteurs

Cristina Arnal (C)

RE-FiT Barcelona Research group. Vall d'Hebron Institute of Research (VHIR) and Parc Sanitari Pere Virgili, Barcelona, Spain. cristinarcar@gmail.com.
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain. cristinarcar@gmail.com.

L Monica Pérez (LM)

RE-FiT Barcelona Research group. Vall d'Hebron Institute of Research (VHIR) and Parc Sanitari Pere Virgili, Barcelona, Spain.

Luís Soto (L)

RE-FiT Barcelona Research group. Vall d'Hebron Institute of Research (VHIR) and Parc Sanitari Pere Virgili, Barcelona, Spain.

Álvaro Casas Herrero (ÁC)

Geriatric Department, Hospital Universitario de Navarra (HUN), Pamplona, Spain.
Navarrabiomed, Hospital Universitario de Navarra(HUN), Universidad Pública de Navarra(UPNA), IdiSNA, Pamplona, Spain.
CIBER of Frailty and Healthy Aging (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.

Joan Ars (J)

RE-FiT Barcelona Research group. Vall d'Hebron Institute of Research (VHIR) and Parc Sanitari Pere Virgili, Barcelona, Spain.
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.

Sonia Baró (S)

RE-FiT Barcelona Research group. Vall d'Hebron Institute of Research (VHIR) and Parc Sanitari Pere Virgili, Barcelona, Spain.
Primary Healthcare Center Larrard, Primary Care Pere Virgili and PiC research group of the IMIM, Barcelona, Spain.

Francisco Díaz (F)

Primary Healthcare Center Bordeta-Magòria, Catalan Health Institute, Barcelona, Spain.

Araceli Abilla (A)

Primary Healthcare Center Bordeta-Magòria, Catalan Health Institute, Barcelona, Spain.

M Belén Enfedaque (MB)

Catalan Health Institute, Barcelona, Spain.

Matteo Cesari (M)

Geriatric Unit, IRCCS Insittuti Clinici Scientifici Maugeri, University of Milan, Milan, Italy.

Marco Inzitari (M)

RE-FiT Barcelona Research group. Vall d'Hebron Institute of Research (VHIR) and Parc Sanitari Pere Virgili, Barcelona, Spain.
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
Faculty of Health Sciences, Open University of Catalonia (UOC), Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH